Cervical Cancer Awareness: Screening and HPV Guide

Cervical Cancer Awareness Month takes place in January, and it is dedicated to creating awareness, supporting safeguards, and encouraging early identification in order to prevent one of the most curable types of cancer. This month is an opportunity to learn more about cervical cancer and to bring attention to the actions that individuals may take to lower their risk of developing the disease and to maintain their health.

  • The significance of cervical screening cannot be overstated.
    Cervical screening serves as a proactive measure in the prevention of cervical cancer, commonly referred to as cancer of the cervix. Cervical screening identifies the presence of human papillomavirus (HPV), a factor that may lead to the development of atypical cells on the cervix. If the test detects HPV, doctors examine the sample for irregular cells.

    At what intervals is it advisable to undergo cervical screening?
    In the initial stages, cervical cancer may not present any noticeable symptoms. Cervical screening usually detects and treats it.
    Cervical cancer symptoms may include:
  • heavier menstrual periods
  • Vaginal bleeding during menstruation, sexual activity, or post-menopause
  • Discharge with an unpleasant odor
  • Sexual discomfort or pain
  • Recurrent urinary infections 
  • back or lower abdominal pain.
    If you experience any of these symptoms, it is advisable to consult with your doctor to have your symptoms evaluated, without any delay. Detecting cervical cancer at an early stage significantly enhances the effectiveness of treatment options available. 

Cervical Cancer Awareness: Screening Options Explained

Options for screening:
The Pap smear and HPV test are the main cervical cancer screening tests. A Pap smear reveals abnormal cervix cells that may become cancerous. HPV tests detect high-risk cervical cancer-causing human papillomaviruses. Early detection and treatment of precancerous alterations improve results with regular tests.

HPV vaccination
The HPV vaccine offers protection against strains of HPV that cause cervical cancer and can benefit both men and women. Doctors recommend the vaccine for preteens aged 11–12 but can be administered as early as age 9. If not vaccinated, individuals up to age 26 should receive the HPV vaccine.

For those aged 27–45 who have not been vaccinated, discussing the benefits of the vaccine with a healthcare provider is advisable. Vaccination at this age group may offer fewer benefits due to prior HPV exposure. However, it can still provide protection. The HPV vaccine prevents new infections but does not treat existing infections or related conditions.

Regular cervical cancer screenings are essential regardless of HPV vaccination status.

This New Year, prioritize your health by resolving to get regular cervical cancer screenings and encourage others to do the same.